Taiwan FDA registration 9622ecab906e025412b858e9bee8fd4b

"Demanson" lipolytic enzyme correction reagent

TW: "德曼遜" 脂解酶校正試劑

Taiwan·Risk Class 2·SIEMENS HEALTHCARE DIAGNOSTICS INC.·Registered Nov 22, 2022 – Nov 22, 2027Active

Registration details

Analysis ID: 9622ecab906e025412b858e9bee8fd4b
Customs Code: DHA05603588500

Company information

Manufacturer: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Manufacturer Country: United States
Authorized Representative: SIEMENS HEALTHCARE LIMITED

Product details

Intended Use: This product is an in vitro diagnostic reagent suitable for lipase (LIP) test correction on the Dimension Clinical Chemistry System.
Product Type (Level 1): A Clinical chemistry and clinical toxicology
Product Type (Level 2): A.1150 Calibrated Products
Import Information: Input;; QMS/QSD

Dates and status

Registration Date: Nov 22, 2022
Expiry Date: Nov 22, 2027

About this record

Access comprehensive regulatory information for "Demanson" lipolytic enzyme correction reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 9622ecab906e025412b858e9bee8fd4b and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS INC.. The authorized representative in Taiwan is SIEMENS HEALTHCARE LIMITED.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.